IVAX: Completes previously announced sale of 53%, or 800,000 shares, to Japanese firm SS Pharmaceuticals for $ 11.4 mil. In addition, IVAX subsidiary Baker Cummins (formerly IVAX Pharmaceuticals) has entered into a cooperative R&D agreement under which SS Pharmaceuticals has exclusive right of first refusal in Japan and other Asian countries to IVAX products and IVAX has similar rights to SS products in the U.S. and Canada. SS Pharmaceuticals is the third largest manufacturer and distributor of OTCs in Japan and has a number of ethical products in development, IVAX says.
You may also be interested in...
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.